Global health initiatives: latest news

Global health initiatives features

Global health initiatives news from aidsmap

More news

Global health initiatives news selected from other sources

  • ViiV Healthcare and CHAI collaboration delivers second milestone with first filing with the FDA of generic dolutegravir by Aurobindo Pharma for the treatment of HIV

    ViiV Healthcare, Aurobindo Pharma, and the Clinton Health Access Initiative, Inc. (CHAI) announced today that Aurobindo Pharma has submitted an Abbreviated New Drug Application (ANDA) for dolutegravir 50mg, for Tentative Approval, to the Food and Drug Administration (FDA), for the treatment of HIV. This is the first ANDA for a generic version of dolutegravir, less than two years after FDA approval of Tivicay® (dolutegravir) for sale in the United States. Upon receiving Tentative Approval from the FDA, Aurobindo Pharma will be able to supply dolutegravir 50mg via the President’s Emergency Plan for AIDS Relief (PEPFAR) programme, following completion of required local regulatory approval process, in the licensed countries outside of the United States, as per the agreement signed between Aurobindo Pharma and ViiV Healthcare in 2014.

    19 hours ago | ViiV Healthcare
  • WHO Advances Research and Development Financing Effort; Global R&D Observatory To Launch In January

    World Health Organization members in committee this week took note of a report by the Consultative Expert Working Group on Research and Development: Financing and Coordination (CEWG), which was set up to find ways to fund research on diseases afflicting poor populations which have little market incentive for the private sector. The report included a proposal for a voluntary pooled fund that would focus on the development of effective and affordable health technologies for such neglected diseases.

    23 hours ago | Intellectual Property Watch
  • World Health Assembly: Experts discuss delinking drug R&D costs from pricing to make them affordable

    The problem of drug prices eating up national health budgetscame up at the annual World Health Assembly, which took place from 18-26 May. Last week, a panel of experts discussed the merits of lowering those prices by delinking research and development costs from pricing.

    23 hours ago | Intellectual Property Watch
  • Civil Society Groups Tell UNITAID: Support access mechanisms led by civil society, not the pharmaceutical industry

    Letters from global groups express deep concerns about the Medicines Patent Pool’s entry into hepatitis C treatment.

    05 May 2015 | Hep C Coalition
  • Pre-exposure prophylaxis works—it's time to deliver

    The science is now clear: oral pre-exposure prophylaxis (PrEP) with a coformulation of tenofovir disoproxil fumarate and emtricitabine (Truvada) significantly reduces the risk of HIV infection among individuals at high risk of HIV infection. The news that PrEP has shown consistent efficacy among those who take it as prescribed should be a cause for celebration, and galvanise action to ensure access to PrEP for those who could benefit the most.

    17 April 2015 | The Lancet
  • "Finally, the Global Fund is focused on human beings": Dybul delivers executive director's report

    Switching gears from a typical executive director's report to the Board during the Global Fund's 33rd meeting on 31 March, Mark Dybul reflected on the six trips he had made in the first quarter of 2015 that demonstrated what he said were the breadth and flexibility inherent in the new funding model.

    02 April 2015 | Global Fund Observer
  • Alert: Serbia is losing harm reduction

    The situation with harm reduction in Serbia is getting increasingly alarming after withdrawal of the Global Fund. Three organizations doing HR programs in Serbia for more than a decade are struggling to maintain services. We want a different future for their beneficiaries. ""Please use your communication with donors to put Serbia back as eligible for funding the harm reduction programs - we keep knocking on closed doors. The EU is the biggest donor here and has no health programs whatsoever; as for other donors, we are ineligible whomever we approach, and keep losing on relevance to the calls,“ says Miodrag Atanasjevic, NGO Veza, Belgrade, Serbia.

    02 April 2015 | Eurasian Harm Reduction Network
  • MSM and transgender people are absent from the Global Fund country dialogue in Eastern Europe and Central Asia

    Men who have sex with men (MSM) and transgender people (TG) are not involved in strategic discussions around HIV in most nations of Eastern Europe and Central Asia (EECA). Lack of reliable epidemiological data, high stigma, and policies that restrict the access of MSM and TG to information on HIV preclude the two key populations from meaningfully participating in the country dialogue processes.

    01 April 2015 | EATG
  • UNAIDS holds virtual consultation for its 2016–2021 Strategy

    UNAIDS is holding its first round of virtual consultations to develop its 2016–2021 Strategy. From 23 March to 2 April, the consultation process will be open to everyone to share information, ideas and experiences on how to accelerate rights-based, evidence-informed action to Fast-Track the AIDS response.

    26 March 2015 | UNAIDS
  • From the Gates Foundation, Direct Investment, Not Just Grants

    The Bill & Melinda Gates Foundation, which has distributed billions of dollars in grants to improve health and living conditions in developing countries, is increasingly expanding its tool kit, using some of its capital to invest directly in companies that could help advance its goals.

    13 March 2015 | New York Times
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.